Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (687)

2025

  1. A machine learning algorithm for the identification elevated Lp(a) in patients with, or high-risk of having, coronary heart disease

    International Journal of Cardiology, Vol. 418

  2. The CNIC polypill (Acetylsalicylic acid + Atorvastatin + Rampril) in secondary prevention of cardiovascular disease in patients with type 2 diabetes: A comparative analysis with alternative therapeutic approaches

    International Journal of Cardiology, Vol. 418

2024

  1. A public value-based model to understand patients’ adoption of eHealth: Theoretical underpinnings and empirical application

    Digital Health, Vol. 10

  2. Achievement of LDL-Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA-AP Study

    Cardiovascular Therapeutics, Vol. 2024

  3. Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degeneration

    Pharmacological Research, Vol. 205

  4. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

    Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618

  5. Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty

    Angiology, Vol. 75, Núm. 2, pp. 175-181

  6. Biocompatibility Testing of UV-Curable Polydimethylsiloxane for Human Umbilical Vein Endothelial Cell Culture on-a-Chip

    ACS Omega, Vol. 9, Núm. 28, pp. 30281-30293

  7. CLINICAL SUSPICION AND INITIAL DIAGNOSTIC STUDIES IN INHERITED METABOLIC DISEASES

    BOLETIN DE PEDIATRIA, Vol. 64, Núm. 267, pp. 29-38

  8. Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers

    Journal of Translational Medicine, Vol. 22, Núm. 1

  9. Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction

    Biochemical Pharmacology, Vol. 230

  10. Characteristics of the phenotypes in prevalent and incident cases of heart failure in primary care: IBERICAN study

    BMC Primary Care, Vol. 25, Núm. 1

  11. Characterization of patients with extensive left atrial myopathy referred for atrial fibrillation ablation: incidence, predictors, and outcomes

    Clinical Research in Cardiology

  12. Classification tree obtained by artificial intelligence for the prediction of heart failure after acute coronary syndromes

    Medicina Clinica, Vol. 163, Núm. 4, pp. 167-174

  13. Combined Sodium-Glucose-Transporters Inhibitors and Glucagon-Like-Peptide Receptor Agonist Compared With Monotherapy Improves Long-Term Survival: A Real-World Registry

    American Journal of Medicine, Vol. 137, Núm. 8, pp. 761-769.e1

  14. Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study

    Diseases, Vol. 12, Núm. 10

  15. Delay in cardiology consultation after primary care physician referrals in heart failure: Clinical implications

    ESC Heart Failure

  16. Design and validation of a new questionnaire with a gender perspective to measure medication adherence for secondary prevention of ischaemic heart disease: study protocol

    BMJ Open, Vol. 14, Núm. 3

  17. Dietary intake of Perfluorooctanesulfonic acid (PFOS) and glucose homeostasis parameters in a non-diabetic senior population

    Environment International, Vol. 186

  18. Early feeding practices and eating behaviour in preschool children: The CORALS cohort

    Maternal and Child Nutrition